High fat diet has lasting effects on the liver

November 9, 2018, Weill Cornell Medical College
Fat cells. Credit: Shutterstock

Consuming a high-fat, high-sugar diet causes a harmful accumulation of fat in the liver that may not reverse even after switching to a healthier diet, according to a new study by scientists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.

For the study, published Oct. 3 in Science Translational Medicine, the investigators developed a nanosensor that can detect and noninvasively track the accumulation of fat in the liver. They used the sensor to assess the effects of a high-fat, high-sugar diet on the livers of mice. They then evaluated the outcomes when the mice returned to a healthy diet. Unexpectedly, the researchers found that, while the decreases after returning to a healthy diet, some residual fat remains in certain liver cells long afterwards.

"Going on a short-term unhealthy diet binge is a bad idea," said senior author Dr. Daniel Heller, an associate professor in the Pharmacology and Physiology, Biophysics and Systems Biology program at the Weill Cornell Graduate School of Medical Sciences and head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering Cancer Center. "The liver remembers."

Nonalcoholic fatty liver (NAFLD) affects up to 30 percent of people in the United States, where a high-fat, high-sugar diet is common. Patients with NAFLD develop an accumulation of excess fat in their livers. The condition can progress to a more serious disease involving inflammation, scarring and even liver cancer (called nonalcoholic steatohepatitis, or NASH). People who accumulate fat inside liver cells called Kupffer cells, specifically a part of these cells named lysosomes that act like cellular garbage collectors, appear more likely to progress to serious liver disease.

"Fatty liver disease is a growing concern in the clinic and has rapidly become one of the top causes of liver disease in the United States and Europe," said co-author and hepatologist Dr. Robert Schwartz, an assistant professor of medicine at Weill Cornell Medicine and an assistant professor in the Physiology, Biophysics and Systems Biology program at the Weill Cornell Graduate School of Medical Sciences. "Currently, we have no medical therapies for fatty liver disease. We tell our patients to eat better and to exercise more, which, as you can imagine, is not very effective."

Currently, some imaging tools like ultrasound or magnetic resonance imaging can help identify people with fatty livers, but these techniques often provide less detailed information. Dr. Heller's nanosensor is the first to noninvasively detect fat in the lysosomes of the Kupffer cells, potentially identifying those most at risk of progressing.

The tiny sensor is about 1,000 times smaller than the width of a human hair and made of single-stranded DNA wrapped around a single-walled carbon nanotube. Fat accumulation in the lysosomes changes the color of light emitted by the nanosensor, and was first observed in live cells in Dr. Heller's lab by MSKCC research associate Prakrit Jena and Weill Cornell Graduate School of Medical Sciences student Thomas Galassi, the first author of the paper.

When the nanosensors are injected into a mouse, the liver filters them out of the blood and then are consumed by the organ's lysosomes. Shining a near-infrared flashlight-like device on rodents injected with these nanosensors causes the sensors to glow. The color of the light corresponds to the fat content in the liver, allowing Dr. Heller and his colleagues to measure fat non-invasively using the device.

In addition to measuring disease progression, these nanosensors may also help accelerate research on fatty disease and its treatment. "A biosensor that could detect this type of fat accumulation could accelerate research towards treatments for and other lipid-linked conditions, and potentially lead to improved diagnostics as well," Dr. Heller said.

Explore further: Study examines the effect of alcohol consumption on survival in non-alcoholic fatty liver

More information: Thomas V. Galassi et al. An optical nanoreporter of endolysosomal lipid accumulation reveals enduring effects of diet on hepatic macrophages in vivo, Science Translational Medicine (2018). DOI: 10.1126/scitranslmed.aar2680

Related Stories

Study examines the effect of alcohol consumption on survival in non-alcoholic fatty liver

October 2, 2018
Non-Alcoholic Fatty Liver Disease (NAFLD), which is not caused by significant alcohol consumption, has become the most common liver disease in the United States and comprises more than two thirds of patients with chronic ...

Researchers uncover potential new role of long noncoding RNA in fatty liver disease

July 30, 2018
Scientists at the University of Michigan Life Sciences Institute have uncovered a potential new role for long noncoding RNA in obesity and nonalcoholic fatty liver disease—an accumulation of too much fat in the liver that ...

More protein after weight loss may reduce fatty liver disease

August 16, 2018
Increasing the amount of protein in the diet may reduce the liver's fat content and lower the risk of diabetes in people with nonalcoholic fatty liver disease (NAFLD). The study is published ahead of print in the American ...

Fat hormone linked to progression of fatty liver disease may hold key to new treatments

November 6, 2017
The rising obesity epidemic has brought with it an army of maladies. One, in particular, is threatening to outpace many of the disorders that accompany obesity, in terms of occurrence and severity: nonalcoholic fatty liver ...

Fatty liver: Turning off TAZ reverses disease

October 27, 2016
Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...

Unveiling the biology behind nonalcoholic fatty liver disease

January 17, 2017
EPFL scientists have discovered a new biological mechanism behind nonalcoholic fatty liver disease.

Recommended for you

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Hybrid prevalence estimation: Method to improve intervention coverage estimations

December 6, 2018
LSTM's Professor Joseph Valadez is senior author on a new study published today in the Proceedings of the National Academy of Sciences, which outlines proposals for a more accurate estimator of health data.

World's smallest wearable device warns of UV exposure, enables precision phototherapy

December 5, 2018
The world's smallest wearable, battery-free device has been developed by Northwestern Medicine and Northwestern's McCormick School of Engineering scientists to measure exposure to light across multiple wavelengths, from the ...

4 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

dogbert
5 / 5 (3) Nov 09, 2018
The title is intentionally misleading. Clearly, the study identified high fat + high sugar diets as contributing factors in fatty liver disease.
Lolke
5 / 5 (2) Nov 09, 2018
What about (the effects of) a high fat OR high sugar diet?
Shootist
1 / 5 (1) Nov 10, 2018
It isn't the fat and you know it. Eat ALL the fat and no sugar have no problem, You go axe an Eskimo about that.
Researcher
not rated yet Nov 11, 2018
In nature sugar is rare.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.